Form 4 for MIRM Mirum Pharmaceuticals, Inc.
Accepted 2023-12-06 00:00:00 ET · period of report 2023-12-05 · accession 0001209191-23-057650 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-12-06 | 2023-12-05 | MIRM | Howe Jolanda | SVP, Gbl Ctrl | S - Sale+OE | $32.40 | -2,500 | 0 | -100% | -$81.0K |
| D | 2023-12-06 | 2023-12-05 | MIRM | Howe Jolanda | SVP, Gbl Ctrl | M - OptEx | $2.94 | +2,500 | 2,500 | New | +$7,350 |
| D | 2023-12-06 | 2023-12-05 | MIRM | Howe Jolanda | SVP, Gbl Ctrl | M - OptEx | $0.00 | -2,500 | 55.4K | -4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-05 | S | D | 2,500 | $32.40 | 0 | D | — | — | |
| 2 | Common | Common Stock | 2023-12-05 | M | A | 2,500 | $2.94 | 2,500 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2023-12-05 | M | D | 2,500 | $0.00 | 55,400 | D | $2.94 · — to 2029-03-11 | 2,500 Common Stock | (F1) 1/4th of the 62,500 shares originally subject to the option vested one year after February 28, 2019, and the balance of the shares vest in a series of 36 successive equal monthly installments at the end of each month thereafter. |